DailyDoctor Archive Specialties Get app
All internal medicine briefings

The edition · Internal Medicine

Sibling comparison finds no link between prenatal paracetamol and autism or ADHD

A Hong Kong cohort of 700,000 mother-child pairs dissolves the paracetamol signal once families are compared with themselves; an updated review ranks weight loss across GLP-1 drugs; and GDF-15 predicts death far better than it diagnoses ischaemia.

The edition in brief

Using sibling-matched cohorts drawn from 708,020 Hong Kong mother-child pairs, prenatal paracetamol exposure was not associated with autism (aHR 1.00, 0.91 to 1.11) or ADHD (aHR 1.01, 0.93 to 1.08). Conventional analyses showed positive associations, but so did paracetamol taken before pregnancy, pointing to family confounding rather than a drug effect. An updated Annals systematic review of 38 trials (25,816 adults without diabetes) reports placebo-subtracted weight loss of up to 5.8% with liraglutide, about 14 to 15% with oral or injectable semaglutide, 12.4% with orforglipron and 19.0% with tirzepatide; gastrointestinal effects affected 76% vs 40% on placebo. In 3,379 patients investigated for suspected functionally relevant coronary disease, GDF-15 diagnosed ischaemia poorly (AUC 0.60) but predicted two-year death well (AUC 0.82), at least as well as troponin T. A network meta-analysis of 21 ICU trials found no nursing add-on, including music, acupressure or longer visiting, significantly better than regular nursing care for delirium.

In this edition

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for internal medicine, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free